Cryoablation has been used for removal of solid cancers in selected settings. We describe its application in a patient who was diagnosed with diffuse large cell lymphoma. A residual lymphoma lesion involving the right adrenal gland, still PET-positive after multiple lines of chemotherapy, was eradicated with the use of cryoablation. The patient is alive and in complete response at last follow-up, over 4 years from the procedure. Our data suggest that cryoablation may have a role also in the setting of lymphoma.
Bassi, G., Ferrari, M., Vanzulli, A., Cantoni, S., Cairoli, R. (2024). Lymphoma’s last therapeutic option: Freeze it!. OPEN JOURNAL OF CLINICAL & MEDICAL CASE REPORTS, 10(5), 1-4.
Lymphoma’s last therapeutic option: Freeze it!
Bassi, G;Ferrari, MB;Cairoli, R
2024
Abstract
Cryoablation has been used for removal of solid cancers in selected settings. We describe its application in a patient who was diagnosed with diffuse large cell lymphoma. A residual lymphoma lesion involving the right adrenal gland, still PET-positive after multiple lines of chemotherapy, was eradicated with the use of cryoablation. The patient is alive and in complete response at last follow-up, over 4 years from the procedure. Our data suggest that cryoablation may have a role also in the setting of lymphoma.File | Dimensione | Formato | |
---|---|---|---|
Cairoli R-2024-Open J Clin Med Case Rep-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
701.27 kB
Formato
Adobe PDF
|
701.27 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.